VORTEX THERAPEUTICS INC
Developing first-in-class therapeutics against the most impactful cancer targets
LOMBARD, United States · Founded 2025 · $1.1M raised
- Headquarters
- LOMBARD, Illinois
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- vortextherapeutics.com
- Total Funding
- $1.1M
About
Vortex Therapeutics is a drug discovery and development company focused on developing small-molecule inhibitors of intrinsically disordered proteins to bring new medicines to cancer patients. The company is developing first-in-class therapeutics against the most impactful cancer targets, with a specific focus on novel mechanisms of action targeting emergent oncogenic pathways. Co-founded by Gary Schiltz, a Research Professor at Northwestern University, Vortex Therapeutics leverages over 20 years of pharmaceutical and clinical experience to advance its oncology pipeline.
Summary
VORTEX THERAPEUTICS INC is a Biotech company based in LOMBARD, United States, founded in 2025. It has raised $1.1M in total.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...